A mutation in the nuclear orphan receptor ROR␣ results in a severe impairment of cerebellar development by unknown mechanisms. We have shown previously that ROR␣ contains a strong constitutive activation domain in its C terminus. We therefore searched for mammalian ROR␣ coactivators using the minimal activation domain as bait in a two-hybrid screen. Several known and putative coactivators were isolated, including glucocorticoid receptor-interacting protein-1 (GRIP-1) and peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP/TRAP220/DRIP205). These interactions were confirmed in vitro and require the intact activation domain of ROR␣ although different requirements for interaction with GRIP-1 and PBP were detected. Even in the absence of exogenous ligand, ROR␣ interacts with a complex or complexes of endogenous proteins, similar to those that bind to ligand-occupied thyroid hormone and vitamin D receptors. Both PBP and GRIP-1 were shown to be present in these complexes. Thus we have identified several potential ROR␣ coactivators that, in contrast to the interactions with hormone receptors, interact with ROR␣ in yeast, in bacterial extracts, and in mammalian cells in vivo and in vitro in the absence of exogenous ligand. GRIP-1 functioned as a coactivator for the ROR␣ both in yeast and in mammalian cells. Thus, GRIP-1 is the first proven coactivator for ROR␣. (Molecular Endocrinology 13: 1550-1557, 1999)
INTRODUCTION
Members of the nuclear receptor superfamily are known to play roles in development, cellular growth, differentiation, and homeostasis (1). The nuclear orphan receptor ROR␣ has been shown to play an important role in cerebellar development, as demonstrated with its mutation in naturally occurring staggerer mice (2) , as well as in targeted knockout experiments (3). The exact mechanism by which ROR␣ mutation leads to this defect is not known. ROR␣ has also been implicated in the transcriptional regulation of the N-myc protooncogene (4) and in the apolipoprotein A-I gene (5) , suggesting potential roles in neoplastic and metabolic processes.
ROR␣ is categorized as an orphan nuclear receptor because it is not known whether it binds a ligand or requires a ligand to activate gene transcription (6) . In the case of nuclear receptors with known ligands, such as thyroid hormone receptor (TR) and retinoic acid receptor, the biological ligands are not found in yeast, rabbit reticulocyte lysate, or in most cultured mammalian cell lines. In these settings, the unliganded receptors interact with corepressor proteins N-CoR (nuclear receptor corepressor) and SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) (7, 8) . In the presence of ligand, these receptors undergo a conformational change, which leads to dissociation of the corepressors and recruitment of coactivators (9) . Several putative nuclear receptor coactivator proteins have been identified, including SRC-1/N-CoA-1, GRIP-1/TIF-2/N-CoA-2, PCIP/ACTR/ AIB1, RIP-140, TRIP-1, TIF-1, TRIP-230, PCAF, TRIP-2/PBP/DRIP205/TRAP220, and CBP (reviewed in Ref. 7) . Several studies have shown that these coactivator proteins are in multiprotein complexes that function, at least in part, by acetylating nucleosomal histones, thereby opening chromatin structure in a manner favorable for gene transcription (reviewed in Ref. 10 ).
We previously showed that ROR␣ contains a Cterminal activation domain that functions both in the context of the native protein and when fused to a heterologous DNA-binding domain (11) . Here we describe a yeast two-hybrid screen using the C-terminal activation domain of ROR␣ as bait that identified interactions between ROR␣ and several known coactivators. Two of these, glucocorticoid receptor-interacting protein-1 (GRIP-1) (12, 13) [also known as hTIF-2 (14) ]rsqb] and peroxisome proliferator-activated receptor (PPAR)-binding protein (PBP) (15) [also known as hDRIP205 (16) , hTRAP220 (17) , and RB18A (18)] were studied in detail. GRIP-1 and PBP interactions correlated with the ability of ROR␣ polypeptides to function as activation domains and were demonstrated both in vitro and in vivo. In addition, endogenous GRIP-1 and PBP were among a complex of proteins that interact with ROR␣. The GRIP-1 and PBP interactions occurred with ROR␣ in a variety of settings including yeast, bacterial extracts, rabbit reticulocyte lysates, and human-derived tissue culture cells, raising the possibility that ROR␣ activation is truly constitutive. Furthermore, GRIP-1 was shown to function as a coactivator for ROR␣ in yeast as well as in mammalian cells.
RESULTS

The C Terminus of ROR␣ Contains a Strong Activation Domain
The C-terminal activation domain of ROR␣ was fused to the DNA-binding domain of the Gal4 transcription factor and transiently transfected into JEG-3 human choriocarcinoma cells. Figure 1 confirms that the region of ROR␣ containing amino acids 272-523 contains a strong activation domain. Moreover, amino acids 272-385 were required for this activation. All of the Gal4 fusion proteins were expressed at comparable levels (data not shown). These results indicate that in addition to the AF2 helix, which has been previously shown to be required for activation by ROR␣ (11, 19) , these more N-terminal amino acids may be required for interaction of ROR␣ with cellular coactivators.
Interaction of ROR␣ Activation Domain with Several Putative Coactivators
The C-terminal activation domain of ROR␣ (amino acids 272-523) was used as bait to screen a 17-day mouse embryo library in yeast, where this activation domain is not functional (data not shown). In addition to double selection, interacting proteins were not considered further if they also interacted with the transcriptionally inactive ROR␣ polypeptide (amino acids 385-523). Table 1 lists the cDNAs that fulfilled these criteria. Remarkably, several of the proteins that interacted with ROR␣ activation domain in the absence of exogenous ligand were identical to proteins called TRIPs that were previously shown by Moore and colleagues (20) to interact with thyroid hormone receptor in a ligand-dependent manner (20) . These included TRIP-1, TRIP-2, and TRIP-11. TRIP-1 is a component of the 26S proteasome, whose physiological role in nuclear receptor function is unclear (21) . Full length TRIP-11 was recently identified as a retinoblastoma protein-and TR-binding protein, called TRIP230 (22) . Full-length TRIP-2 was cloned as a PBP (15) , as well as a component of transcriptionally active complexes that interact with liganded vitamin D receptor (VDR) [DRIP205 (16) and liganded TR (TRAP220) (17) ]. Other coactivators isolated in this screen were TIF-1 (23) and GRIP-1 (12, 13) . In addition, one novel partial cDNA was isolated, but this has been difficult to characterize for technical reasons. In the remainder of this paper, we focus on GRIP-1 and PBP and putative coactiva- 
ROR␣ Interacts with GRIP-1 and PBP in Vitro
The yeast in vivo interactions were next confirmed in vitro. The nuclear receptor interaction domain of GRIP-1 (amino acids 624-1121, containing three LXXLL sequences, also known as NR boxes) and PBP (amino acids 488-739) were expressed as glutathione-S-transferase (GST) fusion proteins in Escherichia coli. Pulldown experiments were carried out using in vitro translated nuclear receptors. Figure 2 demonstrates that ROR␣ interacts with both GRIP-1 and PBP in vitro in the absence of any exogenous ligand. GRIP-1 and PBP interacted with ROR␣ amino acids 272-523 but not with amino acids 385-523, correlating with the transactivation properties of these polypeptides and with the interactions observed in yeast.
Differential Requirements for ROR␣ Interaction with GRIP-1 and PBP
We next studied the effects of mutations in helix 3, which is contained within amino acids 272-385, and helix 12 of ROR␣. The mutations used, V335R and LF510AA, are analogous to mutations in the GRIP-1 interaction surface of TR that have been shown to abrogate ligand-dependent TR activation and interaction with GRIP-1 (25) . Both mutations effectively blocked transcriptional activation by ROR␣ (Fig. 3A) . The helix 12 mutant actually represses transcription, as has been previously described for a mutant in which ROR␣ helix 12 is deleted (11) . As expected from the analogous mutations in TR, both ROR␣ mutants exhibited markedly reduced interactions with GRIP-1 ( Fig. 3B) . Consistent with the importance of 272-385 in ROR␣ interaction with PBP, the helix 3 mutation interacted poorly with ROR␣. Interestingly, however, the helix 12 mutant of ROR␣, although not a transcriptional activator, retained the ability to interact with PBP. This is consistent with the observation that while VDR helix 12 is required for activation as well as for interaction with the DRIP complex, not all conserved residues in helix 12 are required for this interaction, which is dependent upon PBP (16).
Endogenous GRIP-1 and PBP Interact with ROR␣
Recently, liganded nuclear receptors have been shown to interact with endogenous protein complexes that can function as coactivators in cell-free transcription (16, 17, 26) . We compared the abilities of ROR␣ and VDR to interact with endogenous proteins in Namalwa cell nuclear extracts. Figure 4A shows that ligand-bound VDR interacts with a number of nuclear proteins, including proteins in the 230-and 160-kDa range. PBP has previously been shown to be present in this transcriptionally active multisubunit complex (16) . By contrast, unliganded VDR does not interact with these proteins. Interestingly, in the absence of any exogenous ligand, ROR␣ interacts with many proteins, some of which comigrate with those in the liganded VDR complexes (i.e. the DRIP coactivator complex). We next tested whether endogenous GRIP-1 and PBP were in these complexes. Western analysis shows that, indeed, both endogenous GRIP-1 and PBP were bound by ROR␣ (Fig. 4B) and VDR (Fig.  4C) . The ROR␣ interactions occurred in the absence of exogenous ligand, whereas 1,25-(OH) 2 -vitamin D 3 was required for interaction with VDR. The efficiencies of the interactions, assessed semiquantitatively by comparing the amounts of bound and input proteins, were similar for ROR␣ and VDR, with GRIP-1 interacting perhaps more efficiently with liganded VDR than with ROR␣. It is important to note that although both PBP and GRIP-1 are present in the ROR␣ pulldowns, it is not yet clear whether they are in the same or different complexes. In the case of the VDR, they appear to be in different complexes (26) .
GRIP-1 Is a Coactivator for ROR␣ in Yeast
We next sought to determine whether these ROR␣-interacting proteins can actually function as coactivators for ROR␣. GRIP-1 has previously been shown to function as coactivator in yeast for multiple nuclear receptors, including glucocorticoid receptor (12, 13) and TR (27) . To date, such coactivator function has required cognate ligand. Figure 5 clearly demonstrates that full-length GRIP-1 (a generous gift of M. Stallcup) functioned as a strong coactivator for ROR␣, activating transcription 9-fold over control. Importantly, and consistent with interaction data, full-length GRIP-1 did not act as a coactivator for ROR␣ amino acids 385-523 (data not shown). In contrast, PBP did not function similarly as a coactivator in yeast, despite expression Interacting proteins were eluted from the GST-VDR LBD or GST ROR␣ column by incubation with N-lauroyl sarkosine (Sarkosyl). The eluates were separated by SDS-PAGE and analyzed by silver nitrate staining. The approximate molecular mass of the common interacting proteins is shown at the right. B and C, Endogenous GRIP-1 and PBP from Namalwa cells interact with ROR␣ (B) and VDR (C). Namalwa cell nuclear extract (2 mg) was incubated with GST (control), GST-ROR␣, and GST-VDR. Interacting proteins were resolved by SDS-PAGE and blotted using antibodies to GRIP-1 and PBP. Input shown is 10% of amount used in each interaction incubation.
of the full-length protein similar to that achieved for GRIP-1 (data not shown).
GRIP-1 Is a Coactivator for ROR␣ in Mammalian Cells
We next tested the ability of GRIP-1 to function as a coactivator for ROR␣ in mammalian cells, utilizing 293T cells. Unlike yeast, these cells already contain both PBP and GRIP-1, which interacted with ROR␣ as shown in Fig. 6A . ROR␣ interactions did not require any exogenous ligand, whereas TR interacted with both GRIP-1 and PBP in the presence of added T 3 (Fig. 6A) . Figure 6B shows that cotransfection of GRIP-1 potentiated transcriptional activation by ROR␣ (272-523) by more than 2-fold. This modest level of transcriptional potentiation presumably reflects the basal abundance of GRIP-1, that contrasts dramatically with the situation in yeast. Figure 6C shows the incremental effect of transfection on overall GRIP-1 abundance. Transfection efficiency of 293T cells was determined to be 50-70%, indicating that the exogenous GRIP-1 was overexpressed by less than a log order. No stimulation of transcription by ROR␣ (385-523) was observed, again confirming the interaction results. In contrast to the ability of GRIP-1 to potentiate activation by ROR␣, PBP had little or no effect (data not shown) despite expression of PBP at levels that were increased in the transfected levels by approximately the same fold as was observed for transfected GRIP-1 (Fig. 6C) . PBP actually inhibited ROR␣ and TR␣ transcription in some experiments (data not shown). PBP also did not potentiate ROR␣ transcription in other cell types, including JEG-3 cells. Since endogenous PBP is abundant in all of the mammalian cell lines tested, we cannot rule out the possibility that its basal expression is already in excess of what is required for maximal transcription activity. However,
Fig. 5. GRIP-1 Functions as a Coactivator for ROR␣ in Yeast
Yeast was cotransformed with Gal4-ROR␣ 272-523 and either full-length GRIP-1 or full-length PBP in the absence of exogenous ligand. ␤-gal activity was determined and plotted relative to the activity of Gal4-ROR␣ 272-523 alone.
Fig. 6. GRIP-1 Functions as a Coactivator for ROR␣ in Mammalian Cells
A, Endogenous GRIP-1 and PBP from 293T cells interact with ROR␣. 293T whole cell extract (3 mg) was incubated with GST (control), GST-ROR␣, and GST-TRa in the presence or absence of 1 m T 3 . Interacting proteins were resolved by SDS-PAGE and blotted using antibodies to PBP and GRIP-1. Input shown is 4% of the total. B, 293T cells were transfected with the indicated Gal4-ROR␣ expression plasmids and increasing concentration of GRIP-1 expression plasmid (20-320 ng), along with a reporter plasmid containing five GAL4-binding sites upstream of SV40 luciferase. The transcriptional activity in a representative experiment is shown. C, Both GRIP-1 and PBP are expressed above endogenous levels in transfected 293T cells. 293T cells were transfected with 320 ng of GRIP-1, PBP, or pCMX (control) as indicated. Harvested whole-cell extract (75 mg) was resolved by SDS-PAGE and blotted using antibodies to PBP and GRIP-1.
even when cotransfected with GRIP-1, PBP did not potentiate ROR␣ activity (data not shown).
DISCUSSION
The nuclear orphan receptor ROR␣ has been shown to play important roles in brain development (2, 3), lipid metabolism (5), and oncogenesis (28) . Here we show that ROR␣ can interact with several known and putative coactivators, including GRIP-1 and PBP. This is the first demonstration that GRIP-1 can serve as a coactivator for ROR␣. We also demonstrate that a complex of proteins including GRIP-1 and PBP can associate with ROR␣. This observation further supports previous data from other laboratories showing that a complex of coactivator proteins may be involved in mediating nuclear receptor activation function (16, 17, 29) . At the same time, differences in the composition of proteins that interact with ROR␣ suggests that the formation of coactivation complexes may serve as another level of transcriptional regulation.
The dramatic effects of GRIP-1 upon ROR␣ activity in yeast contrasts with the modest potentiation observed in mammalian cells. The most likely explanation is the absence of endogenous coactivator in yeast and its relative abundance in mammalian cells. This could also explain the lack of potentiation by PBP in mammalian cells; in earlier studies PBP only weakly potentiated activation by PPAR (15) and had little or no effect on other receptors (16, 17) . This point is unresolved, however, since while this paper was under review, Treuter et al. (30) reported that PBP contains an activation domain and potently coactivates TR in mammalian cells as well as in yeast. The present observation that full-length PBP does not function as coactivator for ROR␣ in yeast suggests that PBP may not be a coactivator for ROR␣ in the same sense as GRIP-1. Indeed, mutations in helix 12 that abolish activation and interaction with GRIP-1 did not alter PBP interaction. Interestingly, helix 12 is also dispensable for interaction of hepatocyte nuclear factor 4 (HNF4), another ligand-independent nuclear receptor, with the coactivator CBP (31). Unlike GRIP-1 or CBP, PBP does not possess intrinsic histone acetyltransferase activity (data not shown). Rather, the role of PBP is primarily to anchor a multisubunit complex to the nuclear receptor ligand-binding domain (LBD) (16, 17) , thus serving as a bridging subunit of a much larger complex that has a transcriptional activation function (16, 17) .
The fact that exogenous ligand was not necessary to demonstrate coactivator interaction or activation in systems as varied as yeast, bacteria, rabbit reticulocyte, and human cells strongly suggests that ROR␣ is a constitutively active nuclear receptor. The ability of ROR␣ to interact with numerous other proteins that interact with TR only in the presence of endogenous ligand is a further argument that ROR␣ exists in the liganded conformation in the absence of exogenous ligand. While this work was in progress, the constitutively active nuclear receptors HNF4 and constitutive androstane receptor ␤ (CAR␤) were also shown to interact with coactivators in the absence of ligand (31) (32) (33) . Interestingly, androstane ligands lead to dissociation of coactivators from CAR␤ (33) . This raises the possibility that, if there is a ligand for ROR␣, it might inhibit its activity. In this context it is noteworthy that deletion of the AF2 activation helix allows ROR␣ to repress transcription and interact with corepressors (11) , which is normally a characteristic of unliganded hormone receptors (7, 8) .
MATERIALS AND METHODS
Plasmids
The Gal4 reporter used in Fig. 1 has been described previously (34) . The Gal4 reporter construct used in Fig. 5 was kindly provided by M. Brown. pCMX-Gal4 and pCMX-Gal4 ROR␣ 272-523 constructs have been described previously (11) . pCMX-Gal4 ROR␣ 385-523 was constructed from PCR products of pCMX-ROR␣ using the primers 5Ј-CCGGG-GATCCAGTATGCC-3Ј and 5Ј-CTCTGTAGGTAGTTT-GTCC-3Ј and were cloned into the BamHI site of pCMX-Gal4. pSG5 GRIP-1 full length (FL) was kindly provided by M. Stallcup. pcDNA3 PBP will be described elsewhere (26) . ROR␣ 272-523 and 385-523 were subcloned into pGBT9 (CLONTECH Laboratories, Inc., Palo Alto, CA) from the corresponding Gal4 constructs. Helix 3 and Helix 12 mutations in ROR␣ 272-523 were created by PCR. pGAD424 GRIP-1 was kindly provided by M. Stallcup. PBP was subcloned into pGAD424 by standard restriction/ligation procedures. A DNA fragment encoding PBP 488-739, the yeast two-hybrid clone, was subcloned into pGEX-2TK (Pharmacia Biotech, Piscataway, NJ) for preparing GST-fusion protein. A DNA fragment encoding GRIP-1 624-1121 was amplified from pSG5 GRIP-1 using the primers 5Ј-CAGGGATCCGA-CAGGGCTGAGGGACACAG-3Ј and 5Ј-GTTGGATCCG-GACTCCTGACTTGAGAACT-3Ј and cloned into the BamHI site of pGEX-2TK. Plasmids for production of GST-VDR and GST-TR have been previously described (16, 35) . The GST-ROR␣ expression plasmid was constructed by BamHI and XhoI digestion of a PCR fragment amplified from pCMX-ROR␣ using the primers 5Ј-CACGGATCCGAGTCAGCTC-CGGCAGCCCCCGAC-3Ј and 5Ј-GTCGGATCCCATCCGGT-GTTTCTGTACTTC-3Ј, which was ligated into the BamHI site of pGEX-2TK with the 3Ј XhoI and BamHI fragment of pCMX ROR␣. All constructs were confirmed by automated DNA sequencing.
Yeast Two-Hybrid Screen
Saccharomyces cerevisiae HF7c [MATa, 112, LYS2 ::Gal1-HIS3, URA3::(Gal4 17-mers) 3 -CYC1-lacZ] containing pGBT9 ROR 272-523 was transformed with a 17-day mouse embryo library in pGAD10 (CLONTECH Laboratories, Inc.) and plated on SD medium lacking tryptophan, leucine, and histidine (containing 5 mM 3-aminotriazole). His ϩ colonies exhibiting positive ␤-galactosidase activity in the filter lift assay (CLONTECH Laboratories, Inc.) were further characterized. To recover library plasmids, total yeast DNA was isolated, electroporated into E. coli HB101, and isolated on minimal media lacking leucine and containing ampicillin. Isolated plasmid was then cotransformed into HF7c yeast with pGBT9, pGBT9 ROR 272-523, or pGBT9 ROR 385-523 and those plasmids which only exhibited positive ␤-galactosidase activity with pGBT9 ROR 272-523 were further characterized.
Yeast Liquid ␤-Galactosidase Assay
The Y190 strain yeast [MATa, ura3-52, his3-200, lys2-801,  ade2-101, trp1-901, leu2-3, 112, gal4⌬, gal80⌬ , cych r 2, LYS2::Gal1 UAS -HIS3 TATA -HIS3, URA3::Gal1 UAS -Gal1 TATA -lacZ] was cotransformed with pGBT9 ROR 272-523 or pGBT9 ROR 385-523 and pGAD10, pGAD424 GRIP-1, or pGAD424 PBP as indicated. Five independent colonies of each transformation were used to inoculate overnight cultures grown in SD medium lacking tryptophan and leucine. Yeast liquid ␤-galactosidase assays were carried out with each culture in triplicate, using the protocol provided by CLONTECH Laboratories, Inc.
Protein Interaction Assays Using GST Fusion Proteins
GST fusion proteins were expressed in BL21 cells induced with 0.5 mM isopropylthio-␤-O-galactoside at 30 C. Proteins were isolated by cell lysis with lysozyme and detergent followed by sonication. GST beads (50 l) containing the fusion protein were incubated at room temperature in GST binding buffer (50 mM KCl, 20 mM HEPES, pH 7.9, 2 mM EDTA, 0.1% NP-40, 10% glycerol, 0.5% nonfat dry milk, and 5 mM dithiothreitol). In vitro translated protein, using the Promega Corp. TNT T7 Quick kit with [ 35 S]methionine, Namalwa nuclear extracts, or 293T whole-cell extracts were added to the beads as indicated. Binding was allowed to proceed for 1 h, and the beads were washed four times in the same buffer. The bound proteins were eluted by boiling in 30 l of SDS-PAGE loading buffer and resolved by electrophoresis. SDS-PAGE gels performed with in vitro translated protein were dried and visualized by autoradiography. SDS-PAGE gels performed with cellular extract were silver stained or else the proteins were transferred to PVDF membrane for Western blot analysis.
Immunoblotting
Western blots were performed with 1:750 dilution of rabbit polyclonal antibody raised against GRIP-1 624-1121 or PBP 488-739 and a 1:5000 dilution of goat antirabbit IgG-peroxidase (Roche Molecular Biochemicals, Nutley, NJ) secondary as previously described (36) .
Nuclear and Whole-Cell Extract Preparation
293T whole-cell extracts were prepared by washing and harvesting cells in PBS, and subsequent incubation at 4 C for 20 min in lysis buffer or in GST binding buffer containing 1 mM phenylmethylsulfonyl fluoride, 1 mg/ml leupeptin, 1 mg/ml aprotinin, and 1 mg/ml pepstatin. Extracts were quantified using the Bio-Rad assay (Bio-Rad Laboratories, Inc., Richmond, CA). Namalwa B cells were cultured as previously described (16) and nuclear extracts were prepared as previously described (37) .
Cell Culture and Transfection
293T cells were maintained and transfected in DMEM high glucose with 10% FCS. JEG-3 cells were maintained and transfected in DMEM low glucose with 10% FCS. For JEG-3 cells, at 80% confluence, 60-mm dishes were transfected by the calcium phosphate precipitation method using 2 g luciferase reporter, 0.5 g ␤-galactosidase (B-gal) expression vector, and 2 g receptor expression vector. For 293T cells, at 80% confluence, 24-well plates were transfected by the calcium phosphate precipitation method using 50 ng luciferase reporter, 50 ng ␤-galactosidase (␤-gal) expression vector, and 15 ng receptor expression vector and additional coactivator expression vector as indicated. Equivalent amounts of empty expression vector (pCMX) were included in cells transfected with submaximal amounts of receptor or coactivator. Cells were lysed in Triton X-100 buffer, and ␤-gal and luciferase assays were carried out using standard protocols. The measured relative light units were normalized to ␤-gal activity, which served as an internal control for transfection efficiency. Fold activation was calculated as the activity of a given reporter after transfection with control expression vector divided by the activity of the same reporter in the presence of ROR␣ expression vector. Figures show the results of representative experiments in which individual data points were assayed in duplicate and the range of the data is shown. Each experiment was repeated two to five times. The degree of activation from a given site was highly consistent from experiment to experiment.
